142 related articles for article (PubMed ID: 30157875)
1. Chemotherapy induced PRL3 expression promotes cancer growth via plasma membrane remodeling and specific alterations of caveolae-associated signaling.
Csoboz B; Gombos I; Tatrai E; Tovari J; Kiss AL; Horvath I; Vigh L
Cell Commun Signal; 2018 Aug; 16(1):51. PubMed ID: 30157875
[TBL] [Abstract][Full Text] [Related]
2. PRL3 promotes cell invasion and proliferation by down-regulation of Csk leading to Src activation.
Liang F; Liang J; Wang WQ; Sun JP; Udho E; Zhang ZY
J Biol Chem; 2007 Feb; 282(8):5413-9. PubMed ID: 17192274
[TBL] [Abstract][Full Text] [Related]
3. Phosphatase of regenerating liver 3 (PRL3) provokes a tyrosine phosphoproteome to drive prometastatic signal transduction.
Walls CD; Iliuk A; Bai Y; Wang M; Tao WA; Zhang ZY
Mol Cell Proteomics; 2013 Dec; 12(12):3759-77. PubMed ID: 24030100
[TBL] [Abstract][Full Text] [Related]
4. RNAi‑mediated knockdown of PRL‑3 inhibits cell invasion and downregulates ERK 1/2 expression in the human gastric cancer cell line, SGC‑7901.
Cao Y; Tu Y; Mei J; Li Z; Jie Z; Xu S; Xu L; Wang S; Xiong Y
Mol Med Rep; 2013 Jun; 7(6):1805-11. PubMed ID: 23589069
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of GATA zinc finger domain containing 1 through gene amplification promotes liver cancer by directly inducing phosphatase of regenerating liver 3.
Sun W; Zhang Y; Wong KC; Liu K; Yang Y; Wu B; Tong JHM; Chan AWH; Chan HLY; Yu J
Hepatology; 2018 Jun; 67(6):2302-2319. PubMed ID: 29266303
[TBL] [Abstract][Full Text] [Related]
6. PRL-3/PTP4A3 phosphatase regulates integrin β1 in adhesion structures during migration of human ocular melanoma cells.
Foy M; Anézo O; Saule S; Planque N
Exp Cell Res; 2017 Apr; 353(2):88-99. PubMed ID: 28284838
[TBL] [Abstract][Full Text] [Related]
7. PRL3 enhances T-cell acute lymphoblastic leukemia growth through suppressing T-cell signaling pathways and apoptosis.
Garcia EG; Veloso A; Oliveira ML; Allen JR; Loontiens S; Brunson D; Do D; Yan C; Morris R; Iyer S; Garcia SP; Iftimia N; Van Loocke W; Matthijssens F; McCarthy K; Barata JT; Speleman F; Taghon T; Gutierrez A; Van Vlierberghe P; Haas W; Blackburn JS; Langenau DM
Leukemia; 2021 Mar; 35(3):679-690. PubMed ID: 32606318
[TBL] [Abstract][Full Text] [Related]
8. PRL3-DDX21 Transcriptional Control of Endolysosomal Genes Restricts Melanocyte Stem Cell Differentiation.
Johansson JA; Marie KL; Lu Y; Brombin A; Santoriello C; Zeng Z; Zich J; Gautier P; von Kriegsheim A; Brunsdon H; Wheeler AP; Dreger M; Houston DR; Dooley CM; Sims AH; Busch-Nentwich EM; Zon LI; Illingworth RS; Patton EE
Dev Cell; 2020 Aug; 54(3):317-332.e9. PubMed ID: 32652076
[TBL] [Abstract][Full Text] [Related]
9. Engineering of caveolae-specific self-micellizing anticancer lipid nanoparticles to enhance the chemotherapeutic efficacy of oxaliplatin in colorectal cancer cells.
Sundaramoorthy P; Ramasamy T; Mishra SK; Jeong KY; Yong CS; Kim JO; Kim HM
Acta Biomater; 2016 Sep; 42():220-231. PubMed ID: 27395829
[TBL] [Abstract][Full Text] [Related]
10. PRL3 pseudophosphatase activity is necessary and sufficient to promote metastatic growth.
Kozlov G; Funato Y; Chen YS; Zhang Z; Illes K; Miki H; Gehring K
J Biol Chem; 2020 Aug; 295(33):11682-11692. PubMed ID: 32571875
[TBL] [Abstract][Full Text] [Related]
11. PRL3-zumab, a first-in-class humanized antibody for cancer therapy.
Thura M; Al-Aidaroos AQO; Yong WP; Kono K; Gupta A; Lin YB; Mimura K; Thiery JP; Goh BC; Tan P; Soo R; Hong CW; Wang L; Lin SJ; Chen E; Rha SY; Chung HC; Li J; Nandi S; Yuen HF; Zhang SD; Guan YK; So J; Zeng Q
JCI Insight; 2016 Jun; 1(9):e87607. PubMed ID: 27699276
[TBL] [Abstract][Full Text] [Related]
12. PRL‑3 increases the aggressive phenotype of prostate cancer cells in vitro and its expression correlates with high-grade prostate tumors in patients.
Edwards DR; Moroz K; Zhang H; Mulholland D; Abdel-Mageed AB; Mondal D
Int J Oncol; 2018 Feb; 52(2):402-412. PubMed ID: 29207031
[TBL] [Abstract][Full Text] [Related]
13. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW
Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085
[TBL] [Abstract][Full Text] [Related]
14. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
Hsu EC; Kulp SK; Huang HL; Tu HJ; Salunke SB; Sullivan NJ; Sun D; Wicha MS; Shapiro CL; Chen CS
Neoplasia; 2015 Jun; 17(6):497-508. PubMed ID: 26152358
[TBL] [Abstract][Full Text] [Related]
15. PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein.
Thura M; Al-Aidaroos AQ; Gupta A; Chee CE; Lee SC; Hui KM; Li J; Guan YK; Yong WP; So J; Chng WJ; Ng CH; Zhou J; Wang LZ; Yuen JSP; Ho HSS; Yi SM; Chiong E; Choo SP; Ngeow J; Ng MCH; Chua C; Yeo ESA; Tan IBH; Sng JXE; Tan NYZ; Thiery JP; Goh BC; Zeng Q
Nat Commun; 2019 Jun; 10(1):2484. PubMed ID: 31171773
[TBL] [Abstract][Full Text] [Related]
16. Identification of caveolar resident proteins in ventricular myocytes using a quantitative proteomic approach: dynamic changes in caveolar composition following adrenoceptor activation.
Wypijewski KJ; Tinti M; Chen W; Lamont D; Ashford ML; Calaghan SC; Fuller W
Mol Cell Proteomics; 2015 Mar; 14(3):596-608. PubMed ID: 25561500
[TBL] [Abstract][Full Text] [Related]
17. PRL3 induces polypoid giant cancer cells eliminated by PRL3-zumab to reduce tumor relapse.
Thura M; Ye Z; Al-Aidaroos AQ; Xiong Q; Ong JY; Gupta A; Li J; Guo K; Ang KH; Zeng Q
Commun Biol; 2021 Jul; 4(1):923. PubMed ID: 34326464
[TBL] [Abstract][Full Text] [Related]
18. Plasma membrane cyclic nucleotide phosphodiesterase 3B (PDE3B) is associated with caveolae in primary adipocytes.
Nilsson R; Ahmad F; Swärd K; Andersson U; Weston M; Manganiello V; Degerman E
Cell Signal; 2006 Oct; 18(10):1713-21. PubMed ID: 16503395
[TBL] [Abstract][Full Text] [Related]
19. n-3 PUFA alter caveolae lipid composition and resident protein localization in mouse colon.
Ma DW; Seo J; Davidson LA; Callaway ES; Fan YY; Lupton JR; Chapkin RS
FASEB J; 2004 Jun; 18(9):1040-2. PubMed ID: 15084525
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid.
Chen W; Jump DB; Esselman WJ; Busik JV
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):18-26. PubMed ID: 17197511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
